DBV Technologies (DBVT) EPS (Basic) Growth (3y) (2023 - 2026)
Powered by 
Analysis
DBV Technologies (DBVT) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 86.03% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 18.44% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 37.21% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 36.73% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -38.31% |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 67.51% |
| 10 | DBV Technologies | 5.86 Bn | 5.68 Bn | - | 23.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.24% |
| Mar 31, 2026 | 20.21% |
| Dec 31, 2025 | 14.12% |
| Sep 30, 2025 | -9.61% |
| Jun 30, 2025 | 3.69% |
| Mar 31, 2025 | 4.60% |
| Dec 31, 2024 | 1.59% |
| Sep 30, 2024 | 10.23% |
| Jun 30, 2024 | 14.88% |
| Mar 31, 2024 | 19.08% |
| Dec 31, 2023 | 45.59% |
| Sep 30, 2023 | 32.42% |
| Jun 30, 2023 | 33.61% |
| Mar 31, 2023 | 34.81% |